CVS Health is considering breaking up the company to separate its retail and insurance units in an effort to improve its fortunes amid investor pressure. The company has been in discussions with financial advisers about the potential split, following pressure from investors like Glenview Capital. This move comes as CVS faces challenges after lowering its 2024 earnings outlook for the third consecutive quarter in August.
Full Article
Why GeneDx Holdings Stock Blasted 8% Higher Today
GeneDx Holdings (NASDAQ: WGS) saw its stock rise over 8% following a strong second-quarter earnings report that revealed nearly $103 million in revenue, a 49% year-over-year increase, driven by a 69% surge in exome and genome testing sales. This performance stood in stark contrast to the S&P 500's modest 0.3% decline. Want More Context? 🔎
Read more